Pricing
Kalgene is developing a novel fusion protein therapeutic for slowing the progression of Alzheimer’s disease, with technology licensed from the National Research Council of Canada.
Industries
Headquarters
Employees
Links
Org chart
Teams
Offices
Positions (5)
Unverified
0 people · 0 jobs
HQ
Astellas Pharma
52 followers
Tilray
19 followers
Knight Therapeutics
1 follower
AstraZeneca
529 followers
Bayer
459 followers
Bristol-Myers Squibb
297 followers
UCB
83 followers
NYU Langone Health
42 followers
Perrigo
20 followers
West Pharmaceutical Services
11 followers
Dechra Pharmaceuticals
10 followers
View more